Page last updated: 2024-08-21

indirubin and Diabetes Mellitus

indirubin has been researched along with Diabetes Mellitus in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hoda, N; Maqbool, M; Mobashir, M1
Alam, MS; Hamid, H; Khan, I; Tantray, MA1
Eisenbrand, G; Hippe, F; Jakobs, S; Muehlbeyer, S1

Reviews

3 review(s) available for indirubin and Diabetes Mellitus

ArticleYear
Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease.
    European journal of medicinal chemistry, 2016, Jan-01, Volume: 107

    Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Diabetes Mellitus; Glycogen Synthase Kinase 3; Hippocampus; Humans; Hypoglycemic Agents; Inflammation; Molecular Targeted Therapy; Neoplasms; Protein Kinase Inhibitors

2016
Natural and synthetic bioactive inhibitors of glycogen synthase kinase.
    European journal of medicinal chemistry, 2017, Jan-05, Volume: 125

    Topics: Alzheimer Disease; Animals; Bipolar Disorder; Clinical Trials as Topic; Diabetes Mellitus; Drug Discovery; Glycogen Synthase Kinase 3; Humans; Models, Molecular; Neoplasms; Patents as Topic; Phosphorylation; Protein Kinase Inhibitors; Signal Transduction

2017
Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine.
    Journal of cancer research and clinical oncology, 2004, Volume: 130, Issue:11

    Topics: Adenosine Triphosphate; Alzheimer Disease; Antibiotics, Antineoplastic; Cell Cycle; Cyclin-Dependent Kinases; Diabetes Mellitus; Enzyme Inhibitors; Humans; Indoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Medicine, Chinese Traditional; Structure-Activity Relationship

2004